Designing and implementing an integrated non-communicable disease primary care intervention in rural Nepal.
delivery of health care, integrated
global health
implementation research
nepal
non-communicable diseases
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
12
2018
revised:
02
04
2019
accepted:
06
04
2019
entrez:
30
5
2019
pubmed:
30
5
2019
medline:
30
5
2019
Statut:
epublish
Résumé
Low-income and middle-income countries are struggling with a growing epidemic of non-communicable diseases. To achieve the Sustainable Development Goals, their healthcare systems need to be strengthened and redesigned. The Starfield 4Cs of primary care-first-contact access, care coordination, comprehensiveness and continuity-offer practical, high-quality design options for non-communicable disease care in low-income and middle-income countries. We describe an integrated non-communicable disease intervention in rural Nepal using the 4C principles. We present 18 months of retrospective assessment of implementation for patients with type II diabetes, hypertension and chronic obstructive pulmonary disease. We assessed feasibility using facility and community follow-up as proxy measures, and assessed effectiveness using singular 'at-goal' metrics for each condition. The median follow-up for diabetes, hypertension and chronic obstructive pulmonary disease was 6, 6 and 7 facility visits, and 10, 10 and 11 community visits, respectively (0.9 monthly patient touch-points). Loss-to-follow-up rates were 16%, 19% and 22%, respectively. The median time between visits was approximately 2 months for facility visits and 1 month for community visits. 'At-goal' status for patients with chronic obstructive pulmonary disease improved from baseline to endline (p=0.01), but not for diabetes or hypertension. This is the first integrated non-communicable disease intervention, based on the 4C principles, in Nepal. Our experience demonstrates high rates of facility and community follow-up, with comparatively low lost-to-follow-up rates. The mixed effectiveness results suggest that while this intervention may be valuable, it may not be sufficient to impact outcomes. To achieve the Sustainable Development Goals, further implementation research is urgently needed to determine how to optimise non-communicable disease interventions.
Identifiants
pubmed: 31139453
doi: 10.1136/bmjgh-2018-001343
pii: bmjgh-2018-001343
pmc: PMC6509610
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e001343Subventions
Organisme : NIH HHS
ID : DP5 OD019894
Pays : United States
Déclaration de conflit d'intérêts
Competing interests: PA, AA, NC, DC, BD, SD, BG, TG, SH, DJ, SKa, RM, SPa, MP, SPo, IR, AR, PR, AT and RT are employed by and AK, DS, BA, GD, SMa, SMe, RS, LW and DM work in partnership with, a non-profit healthcare company (Nyaya Health Nepal, with support from the USA-based non-profit, Possible) that delivers free healthcare in rural Nepal using funds from the Government of Nepal and other public, philanthropic and private foundation sources. AK is a medical student at and DC, SKi, SMa and DM are faculty members at a private medical school (Icahn School of Medicine at Mount Sinai). DS and RS are employed at an academic medical centre (Brigham and Women’s Hospital) that receives public sector research funding, as well as revenue through private sector fee-for-service medical transactions and private foundation grants. DS and RS are faculty members at a private medical school (Harvard Medical School). DS is employed at an academic medical centre (Beth Israel Deaconess Medical Center) that receives public sector research funding, as well as revenue through private sector fee-for-service medical transactions and private foundation grants. DS is employed at an academic research centre (Ariadne Labs) that is jointly supported by an academic medical centre (Brigham and Women’s Hospital) and a private university (Harvard TH Chan School of Public Health) via public sector research funding and private philanthropy. BA is a faculty member at a public university (University of California, San Francisco). DC is a faculty member at and DC and SH are employed part-time at a public university (University of Washington). GD, BG, SMe, PR and LW are fellows with a bidirectional fellowship programme (HEAL Initiative) that is affiliated with a public university (University of California, San Francisco) that receives funding from public, philanthropic and private foundation sources. GD is employed part-time at a public medical centre (Natividad Medical Center). MD and DJ are employed by the Government of Nepal (Ministry of Health and Population, Nepal Health Research Council and Department of Health Services, respectively). SKa is a graduate student at a private university (Eastern University). BKa and AS are employed at a private university (Kathmandu University). BKa is a faculty member at a public research university (Sun Yat-sen University). SKi is the founding executive director at an advocacy and leadership network (Young Professionals Chronic Disease Network) that receives funding from individual philanthropy. BKo is a faculty member at a public university (Tribhuvan University, Institute of Medicine). LK is a fellow at a public university (Virginia Commonwealth University) and is supported by a Hubert H Humphrey Fellowship from the US Department of State. SMa is a voting member on the Board of Directors with Group Care Global, a position for which she receives no compensation. SMe works in partnership with a public medical center on the border of a Native American reservation (Gallup Indian Medical Center) that is managed using public sector funding through the Indian Health Services. IN is a graduate student at and AS is a postdoctoral fellow at a private university (Harvard T H Chan School of Public Health). IN is a voting member on the Board of Directors with Possible, (a position which she joined after the conclusion of the research described in this manuscript), BP is a member on the Board of Advisors with Nyaya Health Nepal, and DM is a non-voting member on the Board of Directors with Possible, positions for which they receive no compensation. BP is employed at a private medical centre (Hospital for Advanced Medicine and Surgery) that receives revenue from fee-for-service transactions. RS is employed at an academic medical centre (Massachusetts General Hospital) that receives public sector research funding, as well as revenue through private sector fee-for-service medical transactions and private foundation grants. PT is a graduate student at a public university (University of New South Wales). LW works in partnership with a medical center (Gallup Indian Medical Center) that receives revenue through fee-for-service medical transactions and private sector grants. All authors have read and understood BMJ Global Health’s policy on declaration of interests and declare that they have no competing financial interests. The authors do, however, believe strongly that healthcare is a public good, not a private commodity.
Références
Public Health. 2016 Mar;132:3-12
pubmed: 26872738
Global Health. 2012 Jun 11;8:14
pubmed: 22686126
Lancet. 1994 Oct 22;344(8930):1129-33
pubmed: 7934497
J Innov Health Inform. 2017 Jun 23;24(2):862
pubmed: 28749321
J Gen Intern Med. 2017 May;32(5):566-571
pubmed: 27943038
BMJ. 2018 May 21;361:k1716
pubmed: 29784870
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Lancet. 2011 Feb 5;377(9764):450-1
pubmed: 21074257
Healthc (Amst). 2015 Dec;3(4):251-7
pubmed: 26699353
Tob Control. 2010 Oct;19(5):410-6
pubmed: 20675688
ARYA Atheroscler. 2014 Nov;10(6):311-8
pubmed: 25815021
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Br J Gen Pract. 2005 Apr;55(513):305-12
pubmed: 15826439
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
BMC Public Health. 2011 May 13;11:310
pubmed: 21569469
JAMA. 2017 Sep 19;318(11):1016-1025
pubmed: 28975305
Int J Cardiol. 2014 Mar 15;172(2):509-11
pubmed: 24485630
Psychiatr Serv. 2017 Sep 1;68(9):870-872
pubmed: 28760096
Hum Resour Health. 2018 Aug 16;16(1):39
pubmed: 30115074
Ann Intern Med. 2009 Nov 3;151(9):593-601
pubmed: 19884620
WHO South East Asia J Public Health. 2014 Apr-Jun;3(2):154-160
pubmed: 28607301
Lancet Glob Health. 2018 Jan;6(1):e66-e73
pubmed: 29241617
Healthc (Amst). 2018 Sep;6(3):197-204
pubmed: 29880283
Kathmandu Univ Med J (KUMJ). 2022 Jul-Sep;20(79):376-383
pubmed: 37042383
Int J Epidemiol. 2013 Feb;42(1):221-7
pubmed: 23064501
J Clin Hypertens (Greenwich). 2009 Oct;11(10):564-72
pubmed: 19817937
BMC Public Health. 2014 Jul 07;14:694
pubmed: 25002024
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
BMJ Open. 2014 Oct 16;4(10):e005983
pubmed: 25324324
WHO South East Asia J Public Health. 2017 Sep;6(2):69-73
pubmed: 28857065
Science. 2018 Aug 24;361(6404):
pubmed: 30139847
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Acad Psychiatry. 2016 Aug;40(4):667-71
pubmed: 27259491
Trop Med Int Health. 2011 Oct;16(10):1276-84
pubmed: 21733046
BMJ Glob Health. 2018 Jun 22;3(3):e000874
pubmed: 29989034
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582
pubmed: 28128970
Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64
pubmed: 29222377
Trop Med Int Health. 2014 Jan;19(1):47-57
pubmed: 24851259
BMC Health Serv Res. 2017 Mar 27;17(1):237
pubmed: 28347355